Dyspepsia and Helicobacter pylori

Digestive Diseases

Volumn 26, Issue 3, 2008, Pages 210-214

  Selgrad, Michael ^a   Kandulski, Arne ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Dyspepsia; Eradication therapy; Helicobacter pylori

Indexed keywords

ANTIBIOTIC AGENT; PROTON PUMP INHIBITOR;

ATROPHIC GASTRITIS; DYSPEPSIA; ENDOSCOPY; ESOPHAGUS CANCER; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PATHOPHYSIOLOGY; PEPTIC ULCER; PHYSICIAN; PRIORITY JOURNAL; REVIEW; RISK; SOCIOECONOMICS; STOMACH CANCER; UPPER ABDOMINAL PAIN;

ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; DYSPEPSIA; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 43449106213     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121348     Document Type: Review

References (45)

1. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III: Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102:1259-1268.
2. El-Serag HB, Talley NJ: Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004;19:643-654.
3. Quartero AO, Numans ME, Post MW, de Melker RA, de Wit NJ: One-year prognosis of primary care dyspepsia: predictive value of symptom pattern, Helicobacter pylori and GP management. Eur J Gastroenterol Hepatol 2002;14:55-60.
4. Agreus L, Borgquist L: The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002;20:347-355.
5. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN: Functional gastroduodenal disorders. Gut 1999;45 (suppl 2):II37-II42.
6. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al: Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-1479.
7. Talley NJ, Vakil N: Guidelines for the management of dyspepsia. Am J Gastroenterol 2005;100:2324-2337.
8. Delaney BC, Moayyedi P, Forman D: Initial management strategies for dyspepsia. Cochrane Database Syst Rev 2003;2:CD001961.
9. Shah R: Dyspepsia and Helicobacter pylori. BMJ 2007;334:41-43.
10. McNamara D, Buckley M, O'Morain C: Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? More studies should have been included in metaanalysis. BMJ 2000;320:1209-1210.
11. O'Morain C: Role of Helicobacter pylori in functional dyspepsia. World J Gastroenterol 2006;12:2677-2680.
12. El-Omar E, Penman I, Ardill JE, McColl KE: A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 1995;36:534-538.
13. Hall W, Buckley M, Crotty P, O'Morain CA: Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. Clin Gastroenterol Hepatol 2003;1:363-369.
14. Holtmann G, Gschossmann J, Holtmann M, Talley NJ: H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? Dig Dis Sci 2001;46:1550-1557.
15. Quartero AO, de Wit NJ, Lodder AC, Numans ME, Smout AJ, Hoes AW: Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998;43:2028-2033.
16. Stanghellini V, Tosetti C, Paternico A, Barbara G, Morselli-Labate AM, Monetti N, et al: Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996;110:1036-1042.
17. Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998;115:1346-1352.
18. Talley NJ, Verlinden M, Jones M: Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 2001;96:1422-1428.
19. Holtmann G, Goebell H, Talley J: Impaired small intestinal peristaltic reflexes and sensory thresholds are independent functional disturbances in patients with chronic unexplained dyspepsia. Am J Gastroenterol 1996;91:485-491.
20. Talley NJ, Walker MM, Aro P, Ronkainen J, Storskrubb T, Hindley LA, et al: Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based casecontrol study. Clin Gastroenterol Hepatol 2007;5:1175-1183.
21. Talley NJ, Silverstein MD, Agreus L, Nyren O, Sonnenberg A, Holtmann G: AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998;114:582-595.
22. Tytgat G, Hungin AP, Malfertheiner P, Talley N, Hongo M, McColl K, et al: Decision-making in dyspepsia: controversies in primary and secondary care. Eur J Gastroenterol Hepatol 1999;11:223-230.
23. Chiba N, Van Zanten SJ, Sinclair P, Ferguson RA, Escobedo S, Grace E: Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADETHp) randomised controlled trial. BMJ 2002;324:1012-1016.
24. Talley NJ, Vakil N, Delaney B, Marshall B, Bytzer P, Engstrand L, et al: Management issues in dyspepsia: current consensus and controversies. Scand J Gastroenterol 2004;39:913-918.
25. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al: Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-781.
26. Allison JE, Hurley LB, Hiatt RA, Levin TR, Ackerson LM, Lieu TA: A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease. Arch Intern Med 2003;163:1165-1171.
27. Gatta L, Ricci C, Tampieri A, Vaira D: Noninvasive techniques for the diagnosis of Helicobacter pylori infection. Clin Microbiol Infect 2003;9:489-496.
28. Vaira D, Vakil N: Blood, urine, stool, breath, money, and Helicobacter pylori. Gut 2001; 48:287-289.
29. Lassen AT, Hallas J, Schaffalitzky de Muckadell OB: Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients:6.7 year follow up of a randomised trial. Gut 2004;53:1758-1763.
30. Laheij RJ, van Rossum LG, Heinen N, Jansen JB: Long-term follow-up of empirical treatment or prompt endoscopy for patients with persistent dyspeptic symptoms? Eur J Gastroenterol Hepatol 2004;16:785-789.
31. Lassen AT, Pedersen FM, Bytzer P, Schaffalitzky de Muckadell OB: Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000;356:455-460.
32. Arents NL, Thijs JC, van Zwet AA, Oudkerk PM, Gotz JM, van de Werf GT, et al: Approach to treatment of dyspepsia in primary care: a randomized trial comparing 'test-and-treat' with prompt endoscopy. Arch Intern Med 2003;163:1606-1612.
33. McColl KE, Murray LS, Gillen D, Walker A, Wirz A, Fletcher J, et al: Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia. BMJ 2002;324:999-1002.
34. Heaney A, Collins JS, Watson RG, McFarland RJ, Bamford KB, Tham TC: A prospective randomised trial of a 'test and treat' policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut 1999;45:186-190.
35. Klok RM, Arents NL, de VR, Thijs JC, Brouwers JR, Kleibeuker JH, et al: Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting. Clin Ther 2005;27:1647-1657.
36. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;2:CD002096.
37. McCarthy C, Patchett S, Collins RM, Beattie S, Keane C, O'Morain C: Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995;40:114-119.
38. Spiegel BM, Vakil NB, Ofman JJ: Dyspepsia management in primary care: a decision analysis of competing strategies. Gastroenterology 2002;122:1270-1285.
39. Jarbol DE, Kragstrup J, Stovring H, Havelund T, Schaffalitzky de Muckadell OB: Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial. Am J Gastroenterol 2006;101:1200-1208.
40. Malfertheiner P, Sipponen P, Naumann M, Moayyedi P, Megraud F, Xiao SD, et al: Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol 2005;100:2100-2115.
41. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339:1869-1874.
42. Blum AL, Talley NJ, O'Morain C, van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 1998;339:1875-1881.
43. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E: Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ 1999;318:833-837.
44. Malfertheiner P: Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit. Eur J Gastroen terol Hepatol 2001;13(suppl 2):S9-S11.
45. Koelz HR, Arnold R, Stolte M, Fischer M, Blum AL: Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up. Gut 2003;52:40-46.